Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target-Reference-Cited by-同舟云学术

Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target

Published:2020-07-28 Issue:8 Volume:37 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Lapa Beatriz^ORCID,Gonçalves Ana Cristina^ORCID,Jorge Joana^ORCID,Alves Raquel^ORCID,Pires Ana Salomé^ORCID,Abrantes Ana Margarida^ORCID,Coucelo Margarida^ORCID,Abrunhosa Antero^ORCID,Botelho Maria Filomena^ORCID,Nascimento-Costa José Manuel^ORCID,Sarmento-Ribeiro Ana Bela^ORCID

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-020-01394-6.pdf

Reference38 articles.

1. Ghaffari P, Mardinoglu A, Nielsen J. Cancer metabolism: a modeling perspective. Front. Physiol. 2015;6:382. https://doi.org/10.3389/fphys.2015.00382.

2. Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012;491(7424):364–73. https://doi.org/10.1038/nature11706.

3. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–37. https://doi.org/10.1038/nrc3038.